Showing results (21-30 of 496) with videos related to
Sort By:
Pageof 50
Frontiers in Pharmacology|October 5, 2020
Unraveling the Pharmacological Potential of Lichen Extracts in the Context of Cancer and Inflammation With a Broad Screening ApproachRebecca Ingelfinger, Marina Henke, Luise Roser, et al.British Journal of Pharmacology|October 15, 2010
Pharmacogenetics of new analgesicsJörn Lötsch, Gerd GeisslingerNaunyn-Schmiedeberg'S Archives of Pharmacology|April 6, 2006
Cardiovascular risk with cyclooxygenase inhibitors: general problem with substance specific differences?Irmgard Tegeder, Gerd GeisslingerExpert Review of Proteomics|April 12, 2013
Proteomics and NF-κB: an updateEllen Niederberger, Gerd GeisslingerTrends in Pharmacological Sciences|July 4, 2006
Is mPGES-1 a promising target for pain therapy?Klaus Scholich, Gerd GeisslingerDrug Discovery Today|October 22, 2011
Low-dose drug combinations along molecular pathways could maximize therapeutic effectiveness while minimizing collateral adverse effectsJörn Lötsch, Gerd GeisslingerClinical Science (London, England : 1979)|September 17, 2018
The relevance of ceramides and their synthesizing enzymes for multiple sclerosisJennifer Kurz, Robert Brunkhorst, Christian Foerch, et al.Trends in Pharmacological Sciences|May 21, 2010
A critical appraisal of human genotyping for pain therapyJörn Lötsch, Gerd GeisslingerPharmacological Reviews|August 20, 2004
Opioids as modulators of cell death and survival--unraveling mechanisms and revealing new indicationsIrmgard Tegeder, Gerd GeisslingerTrends in Pharmacological Sciences|January 27, 2023
Rethinking the use of NSAIDs in early acute painMarco Sisignano, Gerd GeisslingerPageof 50